Tango Therapeutics Inc.
TNGX | NASDAQ
$22.33
+$0.58 (+2.67%)
At close: Sep 21, 2026, 4:00 PM ET
$21.80
-$0.53 (-2.37%)
Pre-market:
Sep 22, 2026, 9:11 AM ET
Market Data
Market Cap $3.64B
Enterprise Value $2.65B
Beta 1.12
Average Volume 3.46M
Shares Outstanding (Diluted) 149.88M
Shares Change YoY 35.58%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US87583X1090
Price Performance
Price Change 1M -5.1%
Price Change 3M -21.4%
Price Change 6M 6.9%
Price Change YTD 150.1%
Price Change 1Y 199.7%
Price Change 3Y 116.4%
Price Change 5Y 64.7%
1M CAGR (ann.) -17.5%
1Y CAGR (ann.) 183.7%
5Y CAGR (ann.) 7.2%
All-Time CAGR 13.8%
Valuation
PE Ratio -26.27
Forward PE N/A
PEG Ratio -0.66
Forward PEG -1.38
PS Ratio 67.56
Forward PS 1,042.10
PB Ratio 3.55
P/FCF Ratio -25.20
P/Adj. FCF Ratio -19.70
P/OCF Ratio -23.26
EV/Sales 49.31
EV/EBIT -21.44
EV/EBITDA -21.70
EV/FCF -18.39
Earnings Yield -3.8%
FCF Yield -4.0%
Adj. FCF Yield -5.1%
Financial Health
Net Cash $982M
Total Debt $31.99M
Cash & Short-Term Investments $1.01B
Total Assets $1.07B
Current Ratio 50.82
Quick Ratio 50.82
Debt / Equity Ratio 0.03
Debt / EBITDA -0.26
Debt / FCF -0.22
OCF / Debt -4.50
Interest Coverage 0.00
Altman Z-Score 44.09
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 98.3%
Operating Profit Margin -253.4%
EBITDA Margin -227.3%
Net Profit Margin -229.9%
FCF Margin -268.1%
Adj. FCF Margin -343.0%
SBC / Revenue 74.9%
SBC Impact (per share) -27.9%
Returns
Return on Assets -11.5%
Return on Equity -25.7%
Return on Invested Capital -12.9%
Return on Capital Employed -12.9%
Return on Tangible Assets -11.5%
Historical Growth (CAGR)
Revenue CAGR 3Y 16.9%
Revenue CAGR 5Y 19.1%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 13.1%
EPS CAGR 5Y 3.1%
EPS CAGR 10Y N/A
FCF CAGR 3Y -8.5%
FCF CAGR 5Y -9.2%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 13
EPS Growth Next 3Y -17.3%
Revenue Growth Next 3Y 77.9%
Earnings Date Nov 2, 2026
EPS Estimate (next Q) -$0.34
EPS Growth Est (next Q) -361.5%
Revenue Est (next Q) $3.28M
Revenue Growth Est (next Q) -93.9%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $45.91
Price Target Upside 105.6%
Cash Flow
Operating Cash Flow $-143.9M
Free Cash Flow $-144.27M
Adj. Free Cash Flow $-184.56M
FCF Per Share -$0.96
OCF Per Share -$0.96
OCF/S Ratio -267.4%
Income Statement
Revenue $53.81M
Gross Profit $52.87M
Operating Income $-136.35M
EBITDA $-122.29M
Net Income $-123.72M
EPS (Diluted) -$0.85
Revenue / Employee $392.78K
Profit / Employee $-903.07K
Employees 137
Add to Watchlist
Select watchlists to add or remove TNGX